More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (allo-HCT) Meeting Abstract

  

Authors:	Pappacena, J.; Bhatt, V.; Shah, G. L.; Hilden, P.; Maloy, M.; Buie, L. W.; Giralt, S. A.; Scordo, M.
Abstract Title:	More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (allo-HCT)
Meeting Title:	2018 BMT Tandem Meetings
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	24
Issue:	3 Suppl. 1
Meeting Dates:	2018 Feb 21-25
Meeting Location:	Salt Lake City, UT
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2018-03-01
Start Page:	S279
End Page:	S280
Language:	English
ACCESSION:	WOS:000425476000398
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2017.12.271
Notes:	Meeting Abstract: 395 -- Meeting date is incorrect in the original publication's table of contents -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/122630